about
Crystal structure of HIV-1 gp41 including both fusion peptide and membrane proximal external regionsStructural mechanism of trimeric HIV-1 envelope glycoprotein activationMolecular recognition of CCR5 by an HIV-1 gp120 V3 loopVisualizing fusion of pseudotyped HIV-1 particles in real time by live cell microscopy.Energetics of the HIV gp120-CD4 binding reactionThe C terminus of the B5 receptor for herpes simplex virus contains a functional region important for infection.A new class of receptor for herpes simplex virus has heptad repeat motifs that are common to membrane fusion proteins.Molecular recognition of CXCR4 by a dual tropic HIV-1 gp120 V3 loopCrystal structure of glycoprotein C from Rift Valley fever virusDiscovery of small-molecule HIV-1 fusion and integrase inhibitors oleuropein and hydroxytyrosol: Part I. fusion [corrected] inhibitionPotent D-peptide inhibitors of HIV-1 entryDirect inactivation of human immunodeficiency virus type 1 by a novel small-molecule entry inhibitor, DCM205Anti-HIV-1 activity of cellulose acetate phthalate: synergy with soluble CD4 and induction of "dead-end" gp41 six-helix bundles.Development of dengue virus replicons expressing HIV-1 gp120 and other heterologous genes: a potential future tool for dual vaccination against dengue virus and HIVCloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategyInhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein.Natural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief OverviewProtease-resistant peptide design-empowering nature's fragile warriors against HIVRational improvement of gp41-targeting HIV-1 fusion inhibitors: an innovatively designed Ile-Asp-Leu tail with alternative conformations.Alpha-1-antitrypsin interacts with gp41 to block HIV-1 entry into CD4+ T lymphocytes.Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusionMapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein EMembrane interactions of the tick-borne encephalitis virus fusion protein E at low pH.Role of Endocytosis and Low pH in Murine Hepatitis Virus Strain A59 Cell EntrySecretory Leukocyte Protease Inhibitor Binds to Annexin II, a Cofactor for Macrophage HIV-1 InfectionA virocidal amphipathic -helical peptide that inhibits hepatitis C virus infection in vitroA fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodiesPeptide Inhibitors of Dengue-Virus Entry Target a Late-Stage Fusion IntermediateCore structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolutionInhibition of human immunodeficiency virus type 1 infectivity by the gp41 core: role of a conserved hydrophobic cavity in membrane fusionInteractions between HIV-1 gp41 core and detergents and their implications for membrane fusionStructural characterization of the human respiratory syncytial virus fusion protein coreThe trimer-of-hairpins motif in membrane fusion: Visna virusStructural and functional analysis of interhelical interactions in the human immunodeficiency virus type 1 gp41 envelope glycoprotein by alanine-scanning mutagenesis.Mutations that destabilize the gp41 core are determinants for stabilizing the simian immunodeficiency virus-CPmac envelope glycoprotein complexSolution structure of the HIV gp120 C5 domainStructure of the dengue virus envelope protein after membrane fusionDesign of an engineered N-terminal HIV-1 gp41 trimer with enhanced stability and potencyCombinatorial Optimization of a CD4-Mimetic Miniprotein and Cocrystal Structures with HIV-1 gp120 Envelope GlycoproteinMolecular architecture of native HIV-1 gp120 trimers
P2860
Q21090508-633D9CB5-118C-4969-99F8-113806FE184AQ21131394-C2018233-1EA4-4D88-87B0-A4045DBEB93EQ21559473-C75DA4B3-C62B-4BB1-9EA5-BF6AF452ED95Q22241754-D75BFFD3-8EC6-45AB-9F4E-F0805C267018Q22254716-66263991-5C8F-4E10-9651-91CD701DBF48Q24529146-FA39D0C4-4B80-4F4C-8E0F-974756226EB0Q24529147-72EEE99B-8B09-4BE7-BD2D-E6367399E32AQ24616040-89835FE3-D1C5-47CE-AD62-C3E83E9A9C43Q24628170-563C333B-3ED7-4136-AC2C-21463D50865FQ24644512-DBB28467-5111-48AA-9D4E-436E29A7317FQ24675493-266A80A0-3E22-4374-9464-91F6B75A34CBQ24681004-7144B1F3-6546-4091-9F75-7B6976635676Q24791794-A82C9CE4-B16B-49EC-B5DF-F0F1FA15C48CQ24797123-84E0C741-8F6B-41CB-AC48-8D19003C85F6Q24804356-3E9ADA60-23EB-4826-8D7E-C9C6A3B799DBQ24814238-B8D0D84C-B31B-4BA0-8E99-D8C85F32DEF5Q26770401-4EC5EE2B-61CB-4CA3-AB13-0421CBB687B2Q27010058-C385D418-701C-4225-92CD-2F7D369A1AD2Q27315206-DF718AAA-0768-48F2-9538-9B0A31337F5DQ27316160-E5004CF5-D3AB-47F1-940B-623118FB8EE8Q27469690-DAAF69F5-2EDF-48DD-87EF-DBD8FF0D001EQ27469713-A241F931-962D-457D-AEA9-A6FA271C5D00Q27472865-FD61FC5B-BAE3-466C-A920-87AA22BFF5A3Q27481481-0F72B453-4395-4C45-AAE4-9AA1E3B32CF3Q27485184-DE8C4346-B53B-47A8-A7FA-2BB1A2F823D7Q27485575-874109D7-2F7D-4E40-95DB-B8578BA8EACAQ27485578-6956ED60-1F87-48B4-BA99-5AC1E4B10855Q27491339-8BFA7B17-FD1E-4C1A-BA33-F86A741AA728Q27617533-29C622D7-6B5D-4CE6-A08C-408F69D1FAABQ27619600-413005EA-D77D-4C71-882A-8682AF7E019DQ27620993-6826C395-7A1B-448D-8161-4B489280D8F3Q27628799-3451DF77-5880-4A85-AD62-7E2501DDE2D5Q27633137-88DD3129-48AD-43CF-8A89-1CCB46C62652Q27635422-EEE61782-D27B-4C06-82FF-5265FD11D813Q27637675-77505E35-CBE5-4214-AAF2-FDC4B5F27D78Q27639717-42EC6760-CE09-44A7-8356-C539D41170D7Q27643009-B10266B8-FCA3-4C4E-8377-5443C5ADFFACQ27650133-0B558525-3209-4494-B632-752C1A64E548Q27651139-49D79765-431E-41A0-ABAA-5CD346043DC6Q27651385-53E98C36-6096-4A12-8CF5-FDD04F9CF313
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
HIV entry and its inhibition
@ast
HIV entry and its inhibition
@en
HIV entry and its inhibition
@nl
type
label
HIV entry and its inhibition
@ast
HIV entry and its inhibition
@en
HIV entry and its inhibition
@nl
prefLabel
HIV entry and its inhibition
@ast
HIV entry and its inhibition
@en
HIV entry and its inhibition
@nl
P3181
P1433
P1476
HIV entry and its inhibition
@en
P2093
P3181
P356
10.1016/S0092-8674(00)81430-0
P407
P577
1998-05-29T00:00:00Z